MAZ-101

· EMS

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MAZ-101, covering 2024-02-16 to 2024-02-16. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of MAZ-101 in the Treatment of Persistent Allergic Rhinitis (PER) [Phase 3]